Literature DB >> 21221786

Absence of mucosal inflammation in uncomplicated diverticular disease.

Luca Elli1, Leda Roncoroni, Maria Teresa Bardella, Claudia Terrani, Antonella Bonura, Michele Ciulla, Stefano Marconi, Luca Piodi.   

Abstract

BACKGROUND: Uncomplicated diverticular disease is a common condition in patients older than 50 years. Symptoms are aspecific and overlapping with those of irritable bowel syndrome. Nowadays, patients are often treated with antinflammatory drugs (5-aminosalicilic acid). AIM: Our purpose was to evaluate the presence of inflammation in the colonic mucosa of patients with symptomatic uncomplicated diverticular disease compared with subjects without diverticula.
METHODS: Endoscopic biopsies of colon from 10 patients with symptomatic uncomplicated diverticular disease and 10 from subjects without diverticula (controls) were taken. Specimens were homogenised and IL2, IL4, IL5, IL8, IL10, IL12p70, IL13, IFN gamma, TNF alfa (searchlight multiplex technique), TGF beta, transglutaminase type 2 and caspase 9 were measured. Histochemistry for transglutaminase type 2 and TUNEL were performed on the histological sections, in addition to morphologic evaluation, as markers of tissue remodelling and apoptosis. For statistical analysis Student's t test and Spearman correlation test were used.
RESULTS: No histological differences were detected between the patients with an uncomplicated diverticular disease and controls. Mean values of mucosal cytokines and of the other tested parameters did not show statistically significant differences between patients with uncomplicated diverticular disease and controls.
CONCLUSIONS: Even if based on a small number of patients, the study demonstrates the absence of inflammation in the mucosa of subjects affected by uncomplicated diverticular disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221786     DOI: 10.1007/s10620-010-1547-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

Review 1.  Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery.

Authors:  L Köhler; S Sauerland; E Neugebauer
Journal:  Surg Endosc       Date:  1999-04       Impact factor: 4.584

2.  Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study.

Authors:  Antonio Tursi; Giovanni Brandimarte; Gian Marco Giorgetti; Walter Elisei
Journal:  J Clin Gastroenterol       Date:  2006-04       Impact factor: 3.062

Review 3.  Immunity, inflammation, and allergy in the gut.

Authors:  Thomas T Macdonald; Giovanni Monteleone
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

4.  Long-standing colonic inflammation is associated with a low prevalence of diverticuli in inflammatory bowel disease patients.

Authors:  Adi Lahat; Benjamin Avidan; Simon Bar-Meir; Yehuda Chowers
Journal:  Inflamm Bowel Dis       Date:  2007-06       Impact factor: 5.325

Review 5.  Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders.

Authors:  S Goriely; R Cavoy; M Goldman
Journal:  Allergy       Date:  2009-05       Impact factor: 13.146

Review 6.  Novel therapeutic approaches in IBS.

Authors:  Sylvie Bradesi; Emeran A Mayer
Journal:  Curr Opin Pharmacol       Date:  2007-11-19       Impact factor: 5.547

7.  Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells.

Authors:  Catherine Wilson; Timothy Wilson; Patrick G Johnston; Daniel B Longley; David J J Waugh
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

Review 8.  Advances in the pathogenesis and treatment of IBD.

Authors:  Nicholas A Braus; David E Elliott
Journal:  Clin Immunol       Date:  2009-03-24       Impact factor: 3.969

Review 9.  Diet, ageing and genetic factors in the pathogenesis of diverticular disease.

Authors:  Daniel Martin Commane; Ramesh Pulendran Arasaradnam; Sarah Mills; John Cummings Mathers; Mike Bradburn
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

Review 10.  Modulation of TGF-beta signaling during progression of chronic liver diseases.

Authors:  Koichi Matsuzaki
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  4 in total

Review 1.  Advances in the management of colonic diverticulitis.

Authors:  Antonio Tursi
Journal:  CMAJ       Date:  2012-08-27       Impact factor: 8.262

2.  Colonic Diverticula Are Not Associated With Mucosal Inflammation or Chronic Gastrointestinal Symptoms.

Authors:  Anne F Peery; Temitope O Keku; Cassandra Addamo; Amber N McCoy; Christopher F Martin; Joseph A Galanko; Robert S Sandler
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-08       Impact factor: 11.382

Review 3.  Paradigm shift: the Copernican revolution in diverticular disease.

Authors:  Angelo Zullo; Luigi Gatta; Roberto Vassallo; Vincenzo De Francesco; Raffaele Manta; Fabio Monica; Giulia Fiorini; Dino Vaira
Journal:  Ann Gastroenterol       Date:  2019-08-02

Review 4.  Progress and challenges in the management of diverticular disease: which treatment?

Authors:  Angel Lanas; Daniel Abad-Baroja; Aitor Lanas-Gimeno
Journal:  Therap Adv Gastroenterol       Date:  2018-07-23       Impact factor: 4.409

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.